These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8310483)

  • 1. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
    Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
    Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
    Myhre BA; Jiminez L; Shitabata P; Ukkestad TS
    Ann Clin Lab Sci; 1994; 24(1):76-83. PubMed ID: 7511879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrafamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population.
    al Nasser MN
    Ann Trop Paediatr; 1992; 12(2):211-5. PubMed ID: 1381898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
    Kuperan P; Choon AT; Ding SH; Lee G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibody to hepatitis C virus in a blood donor population.
    Richards C; Holland P; Kuramoto K; Douville C; Randell R
    Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
    Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
    Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
    Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
    Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels.
    Hetland G; Skaug K; Larsen J; Maland A; Strømme JH; Størvold G
    Transfusion; 1990; 30(9):776-9. PubMed ID: 2173175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus antibodies in high-risk Saudi groups.
    Bahakim H; Bakir TM; Arif M; Ramia S
    Vox Sang; 1991; 60(3):162-4. PubMed ID: 1907415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
    Li F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis E virus in male blood donors in Jeddah, Saudi Arabia.
    Abdelaal M; Zawawi TH; al Sobhi E; Jeje O; Gilpin C; Kinsara A; Osoba A; Oni GA
    Ir J Med Sci; 1998; 167(2):94-6. PubMed ID: 9638024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropositivity to hepatitis C virus in Saudi haemodialysis patients.
    al Nasser MN; al Mugeiren MA; Assuhaimi SA; Obineche E; Onwabalili J; Ramia S
    Vox Sang; 1992; 62(2):94-7. PubMed ID: 1325714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of antibodies to hepatitis C (anti HCV) in blood donors in Rio de Janeiro, Brazil. Its relation to ALT and anti HBC].
    Leite NC; Nogueira CM; Coelho HS; Perez R; Martins SJ; Soares JA; Junqueira PC
    Arq Gastroenterol; 1992; 29(1):5-11. PubMed ID: 1307202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese.
    Lin CK; Chu R; Li KB; Leong S
    Vox Sang; 1992; 62(2):98-101. PubMed ID: 1325715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-hepatitis C virus in the blood donor population of Rio de Janeiro.
    Vanderborght BO; Reis AM; Rouzere CD; da Silva RS; Yoshida CF; Franco LG; Maertens G; Van Heuverswijn H; Moreira Pereira J
    Vox Sang; 1993; 65(2):122-5. PubMed ID: 7692672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
    Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
    Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.